Bavencio (avelumab)

avelumab · Merck KGaA (EMD Serono in some markets)

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Bavencio (avelumab), covering 2023-01-04 to 2025-02-14. Get the full timeline:

Most recent: Clinical Trial Update: Role of PRoactivE Coaching on PAtient REported Outcome in Advanced or Metastatic RCC Treated With Sunitinib or a Combination of Pembrolizumab + Axitinib or Avelumab + Axitinib in First Line Therapy [Phase 3]

See pricing